Institute for International Health and Education, Albany, NY, USA.
Department of Social and Behavioral Sciences, Yale School of Public Health, 50296Yale University, New Haven, CT, USA.
Int J STD AIDS. 2021 Jul;32(8):678-686. doi: 10.1177/0956462420984696. Epub 2021 Mar 26.
Tajikistan, a country of approximately nine million people, has a relatively small but quickly growing HIV epidemic. No peer-reviewed study has assessed factors associated with HIV, or associated risk factors, among female sex workers (FSWs) in Tajikistan. The purpose of the current study is to elucidate the factors associated with HIV status and risk factors in the Tajikistani context and add to the scant literature on risk factors among FSWs in Tajikistan and Central Asia. We used cross-sectional data from an HIV bio-behavioral survey (BBS) conducted among FSWs in the Republic of Tajikistan ( = 2174) in 2017. Using Respondent Driven Sampling Analysis Tool software, we calculated the prevalence of HIV, diagnosed cases, linkage to antiretroviral therapy (ART), and the prevalence of syphilis for FSWs in Tajikistan. Prevalence data were adjusted for network size and any clustering effects in the network. Further, using univariate and multivariable logistic regression, we determined correlates of HIV-positive status. Results were as follows: Of all FSWs in Tajikistan, 2.6% (95% CI: 1.7-3.8%) are HIV positive, 2.3% (95% CI: 1.4-3.5%) are diagnosed and aware of their status, and 2.0% (95% CI: 1.2-3.1%) are on ART. About 5.7% (95% CI: 4.5-7.4%) of FSWs in Tajikistan have ever had syphilis, and 0.8% (95% CI: 0.4-1.3%) have active syphilis infections. The epidemic of injection drug use was found to be strongly synergistic with HIV infection as having had sex with a person who injects drugs was shown to be strongly associated with HIV-positive status (OR: 5.2; 95% CI: 2.6-10.2) in the multivariable model. While this study estimates that HIV prevalence among Tajikistani FSWs is relatively low, it is likely an underestimated due to selection and social desirability biases. To curb the small, but potentially volatile, HIV epidemic among FSWs, the government should consider targeted testing and linkage-to-care efforts for FSWs who inject drugs or who have people who inject drugs partners. Services should also be prioritized in Gorno-Badakhshan, which has a higher number of FSWs per capita relative to other regions. Additionally, the link between HIV and experiences of stigma, violence, and discrimination against FSWs should motivate advocates to protect Tajikistani FSWs from these experiences.
塔吉克斯坦是一个拥有约 900 万人口的国家,其艾滋病疫情相对较小,但呈快速增长趋势。目前,还没有经过同行评审的研究评估过塔吉克斯坦女性性工作者(FSW)中与艾滋病毒相关的因素或相关的风险因素。本研究的目的是阐明与塔吉克斯坦背景下 HIV 状况和风险因素相关的因素,并补充关于塔吉克斯坦和中亚地区 FSW 风险因素的文献。我们使用了 2017 年在塔吉克斯坦共和国(=2174)进行的 HIV 生物行为调查(BBS)中的横断面数据。我们使用应答者驱动抽样分析工具软件计算了塔吉克斯坦 FSW 的艾滋病毒流行率、确诊病例、与抗逆转录病毒治疗(ART)的联系以及梅毒的流行率。流行率数据经过网络规模和网络中任何聚类效应的调整。此外,我们使用单变量和多变量逻辑回归确定了 HIV 阳性状态的相关因素。结果如下:在所有塔吉克斯坦的 FSW 中,2.6%(95%CI:1.7-3.8%)呈 HIV 阳性,2.3%(95%CI:1.4-3.5%)被诊断并知晓自己的状况,2.0%(95%CI:1.2-3.1%)正在接受抗逆转录病毒治疗。大约 5.7%(95%CI:4.5-7.4%)的塔吉克斯坦 FSW 曾患有梅毒,0.8%(95%CI:0.4-1.3%)患有活动性梅毒感染。注射毒品的流行情况与 HIV 感染呈强烈协同作用,因为与注射毒品的人发生性关系与 HIV 阳性状态密切相关(OR:5.2;95%CI:2.6-10.2)在多变量模型中。虽然这项研究估计塔吉克斯坦 FSW 的 HIV 流行率相对较低,但由于选择和社会期望偏差,这可能是一个被低估的数字。为了遏制注射毒品或有注射毒品伴侣的 FSW 中规模虽小但可能不稳定的 HIV 疫情,政府应考虑针对这些人群进行有针对性的检测和与护理联系。应优先考虑戈尔诺-巴达赫尚地区的服务,该地区每千人的 FSW 人数相对其他地区更高。此外,HIV 与 FSW 遭受耻辱、暴力和歧视的经历之间的联系应促使倡导者保护塔吉克斯坦 FSW 免受这些经历的影响。